Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

UCB SA (0NZT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
118.90 -1.20    -1.00%
- Real-time Data. Currency in EUR ( Disclaimer )
  • Volume: 1,740
  • Bid/Ask: 117.80 / 120.35
  • Day's Range: 118.50 - 119.05
Type:  Equity
Market:  United Kingdom
ISIN:  BE0003739530 
SEDOL:  B28MZM8
UCB 118.90 -1.20 -1.00%

0NZT Share Price Overview

 
Assess today's live UCB SA (UCB) share price, performance and insights using our live Brussels: UCB stock exchange data.

Analyse the historical data and UCB SA share price performance charts on this page. Our technical summary section provides analysis on UCB share price buy/sell indicators using real-time data (or discuss the UCB (UCB) stock price today with other investors in the UCB EBR share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current EBR UCB share price (ISIN: BE0003739530) to enhance your trading decisions with our free investment tools and resources.

What Is the UCB SA Share Price Today?
The UCB share price today is 118.90.

What Is the Stock Symbol for UCB SA
The stock symbol (or 'ticker') for UCB SA is "UCB."

What Stock Exchange Does UCB SA Trade On?
UCB SA is listed and trades on the Brussels stock exchange.

Is UCB SA a Good Stock to Buy?
Determining whether UCB SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close120.1
Day's Range118.5 - 119.05
Revenue5.18B
Open118.8
52 wk Range65.48 - 122.5
EPS1.81
Volume1,740
Market Cap22.62B
Dividend (Yield)0.931 (0.78%)
Average Volume (3m)198,123
P/E Ratio65.66
Beta0.399
1-Year Change39.26%
Shares Outstanding189,750,583
Next Earnings DateApr 24, 2024
What is your sentiment on UCB?
or
Vote to see community's results!

Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Sell Sell Sell Buy Buy
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Buy Strong Buy
Summary Strong Sell Strong Sell Strong Sell Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Advance Block Bearish 1M Current
Completed Patterns
Three Black Crows 1H 3 Apr 18, 2024 16:00
Engulfing Bearish 1W 5 Mar 10, 2024
Tri-Star Bullish 15 9 Apr 18, 2024 16:30

UCB SA Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Brussels 119.10 0.00 0.00 28,280 -0.75% EUR  
  BATS Europe 118.28 0.00 0.00 0 0.00% EUR  
  OTC Markets 63.68 0.00 0.00 7,177 -0.61% USD  
  London 118.90 117.80 120.35 1,740 -1.00% EUR  
  TradeGate 118.45 119.05 119.15 87 -0.92% EUR  
  Frankfurt 118.20 119.05 119.15 0 -1.95% EUR  
  Vienna 107.55 107.55 108.75 0 +0.00% EUR  

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  IAG 167.23 167.45 162.15 -2.58 -1.52% 10.26M 11:10:23  
  EasyJet 524.00 529.00 514.57 -6.00 -1.13% 1.09M 11:10:07  
  Rolls-Royce Holdings 396.80 399.00 391.20 -5.70 -1.42% 8.58M 11:10:21  
  Lloyds Banking 50.60 50.83 50.20 -0.40 -0.78% 32.70M 11:10:13  
  Ocado 343.10 349.40 341.20 -6.90 -1.97% 467.85K 11:09:53  
  BP 508.70 514.40 504.20 -3.70 -0.72% 9.87M 11:10:14  
  BAE Systems 1,300.00 1,301.00 1,280.50 +13.00 +1.01% 1.48M 11:10:22  
  Centamin 127.30 128.40 126.60 -0.80 -0.63% 1.08M 11:05:25  
  HSBC 639.20 639.20 633.80 -5.40 -0.84% 6.31M 11:10:23  
  Barclays 183.98 184.08 181.50 0.00 0.00% 10.53M 11:10:23  

%SHORT_NAME% Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

8767

Equity Type

DRC

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company’s primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson’s disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer’s disease; minzasolmin and UCB0222 for Parkinson’s disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

UCB Price Commentary

Write your thoughts about UCB L
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email